本文選題：超藥品說明書用藥 + 循證藥學��； 參考：《中國醫(yī)院藥學雜志》2017年13期

【摘要】：目的:利用循證藥學模式規(guī)范超說明書用藥,為臨床合理的超說明書用藥提供依據(jù),對不合理的使用給予預警或干預。方法:臨床藥師2015年每月隨機抽取某院門診處方100份,對有超說明書用藥的處方進行分類統(tǒng)計,并通過中外數(shù)據(jù)庫、典籍、指南等循證依據(jù),依照證據(jù)質(zhì)量提出超說明書用藥的推薦強度和干預措施。結(jié)果:抽調(diào)的1 200份處方中有50.08%的處方存在超說明書用藥,超說明書用法的分類及各分類所占總處方的比例分別為超用法用量(24.25%)、超適應證用藥(13.75%)和超適用人群(12.08%)。對所涉及的23類超說明書使用藥品循證分析后,為醫(yī)生提供了3種公認有益(Ⅰ級推薦)的超說明書用法,并且對10類Ⅱb/Ⅲ級推薦的超說明書用藥進行干預,共有6類超說明書用法在處方干預前后得到明顯的改善。結(jié)論:利用循證藥學方法不僅可以為醫(yī)生合理的超說明書用藥提供保障,更有助于醫(yī)生接受和采納臨床藥師的合理建議,減少超說明書用藥風險。
[Abstract]:Objective: to provide evidence for rational drug use in clinical practice and to provide early warning or intervention for irrational use. Methods: in 2015, the clinical pharmacists randomly selected 100 prescriptions from outpatient clinics in a certain hospital in 2015, and classified the prescriptions with overprescriptions, and used the evidence bases of Chinese and foreign databases, classics, guidelines, etc. According to the quality of evidence, the recommended strength and intervention measures of the drug were put forward. Results: 50.08% of the 1 200 prescriptions were superprescriptions. The proportion of overdose and the proportion of each classification to the total prescriptions were 24.25%, 13.75% and 12.08%, respectively. Evidence-based analysis of the 23 kinds of superscript involved provided doctors with 3 kinds of superscript usages that were recognized as beneficial (grade 鈪，

本文編號：1850249